PET/CT在淋巴瘤中的应用
出处
《中国实验诊断学》
北大核心
2009年第4期565-568,共4页
Chinese Journal of Laboratory Diagnosis
基金
吉林省科技厅科研基金资助(200705150)
参考文献25
-
1Olivier P. Nuclear oncology, a fast growing field of nuclear medicine. Nucl Instrum & Meth in Phys Res,2004,527:4.
-
2Maldonado A, Gonzalez- Alenda FJ, Alonso M, et al. PET-CT in clinical oncology. Clin Transl Oncol,2007,9(8) :494.
-
3Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology, Lancet Oncol,2001,2 (3) : 157.
-
4Stumpe KD, Urbinelli M, Steinert HC, et al. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomngraphy[ J]. Eur J Nucl Med, 1998,25 (7) :721.
-
5陈莉莉,曾晓颖,陈钰,李军民,钱樱,沈志祥.^(18F-)FDG PET显像对淋巴瘤的诊断价值[J].肿瘤,2002,22(3):256-256. 被引量：1
-
6Partridge S, Timothy A, O' Doherty MJ, et al. 2-Fluorine-18-fluoro-2-de- oxy-d-glucose positron emission tomography in the pretreatment staging of Hodgkin' s disease: influence on patient management in a single institution [J]. Ann Oncol,2000, 11(10): 1273.
-
7Andrew W, Marcus F, John FS, et al. Impact of 18F fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-Hodgkin lymphoma[ J]. Int J Radiat Oncol, 2008,71 ( 1 ) : 213.
-
8Ribrag V, Vanel D, Leboulleux S, et al. Prospective study of bone marrow in filtration in aggressive lymphoma by three independent methods: Wholebody MRI,PET/CT and bone marrow biopsy[J]. Eut J Radiol,2008,66 (2) :325.
-
9Shah N, Hoskin P, McMillan A, et al. The impact of FDG positron emission tomography imaging on the management of lymphomas. Br J Radiol,2000, 73 (869) : 482 - 487.
-
10Wang JP, Sun HR, Bai RJ, et al. IBF-FDG PET/CT images in primary adrenal lymphoma[J] .Eur J Radiol Extra,2008.
二级参考文献4
-
1田嘉禾.PET在淋巴瘤诊断方面的应用[J].实用肿瘤杂志,2005,20(2):102-105. 被引量：7
-
2L. S. Freudenberg,G. Antoch,P. Schütt,T. Beyer,W. Jentzen,S. P. Müller,R. G?rges,M. R. Nowrousian,A. Bockisch,J. F. Debatin. FDG-PET/CT in re-staging of patients with lymphoma[J] 2004,European Journal of Nuclear Medicine and Molecular Imaging(3):325～329
-
3赵军,林祥通.^(18)F-FDG PET诊断肿瘤应考虑的几个问题[J].国外医学（放射医学核医学分册）,1999,23(6):241-245. 被引量：8
-
4马潞娜,金泉,李立伟,刘京璇,高和,白丽.^(18)F-FDG PET显像对肺癌组织学类型的判断价值[J].中华核医学杂志,2000,20(3):135-135. 被引量：8
-
1白景明,李亚明.体内多药耐药的显像研究[J].国外医学（放射医学核医学分册）,1999,23(5):208-212.
-
2王荣福,陈雪祺.PET/CT在消化系肿瘤应用的现状与进展[J].世界华人消化杂志,2016,24(35):4652-4659. 被引量：3
-
3张步林,胡兵.超声造影在肝脏功能显像上的研究进展[J].临床超声医学杂志,2006,8(11):680-683. 被引量：2
-
4马佶赟,石洪成.PET—CT在结直肠癌肝转移诊治中的应用进展[J].国际放射医学核医学杂志,2010,34(4):212-216.
-
5吴媛,刘小兰,苏丽萍.^18F-FDG PET-CT评价淋巴瘤骨髓浸润的临床价值[J].国际肿瘤学杂志,2016,43(8):634-637. 被引量：2
-
6李方明,赵文锐,聂青,王瑞民,朱奇,梁英魁,康静波,张丽萍,杨平,张军.脑神经胶质瘤碳标记胆碱PET—CT功能显像与MRI对比分析[J].中华放射肿瘤学杂志,2010,19(5):413-414.
-
7杨国仁,孙晓蓉.肺癌多药耐药功能显像研究进展[J].国外医学（肿瘤学分册）,2002,29(5):381-385. 被引量：2
-
8王芬,刘楠楠,申东兰.卵巢癌多药耐药^(99m)Tc-MIBI显像的研究现状及临床应用进展[J].现代肿瘤医学,2009,17(7):1372-1375. 被引量：1
-
9李少华,王自正,王峰,姚薇萱,邵国强,蒋娥,张乐乐,孟庆乐.^(131)I治疗分化型甲状腺癌患者唾液腺损伤的影响[J].南京医科大学学报（自然科学版）,2010,30(7):998-1001. 被引量：13
-
10程月新,徐卫,李建勇.PET/CT在淋巴瘤诊治中的应用[J].现代肿瘤医学,2007,15(9):1339-1341. 被引量：2
